PALATIN TECHNOLOGIES INC (PTN) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US6960776010
PALATIN TECHNOLOGIES INC financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 0.00 USD | 8.83 m USD |
| Operating income | -17.46 m USD | -8.67 m USD |
| EBIT | -17.29 m USD | -16.75 m USD |
| Net income | -17.31 m USD | -8.38 m USD |
| Diluted EPS – continuing operations | -32.15 USD | -2.96 USD |
Full history since 1996, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About PALATIN TECHNOLOGIES INC
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
More stocks
- HYDROFARM HOLDINGS GROUP, INC. (HYFM)
- STANDARD PREMIUM FINANCE HOLDINGS, INC. (SPFX)
- Neonode Inc. (NEON)
- URBAN ONE, INC. (UONEK)
- United Health Products, Inc. (UEEC)
- Vistagen Therapeutics, Inc. (VTGN)
- Concrete Leveling Systems Inc (CLEV)
- Sintx Technologies, Inc. (SINT)
- Trio Petroleum Corp (TPET)
- Lifeward Ltd. (LFWD)
- Lexaria Bioscience Corp. (LEXX)
- AVALON HOLDINGS CORP (AWX)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.